Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor (Q39335219)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor (English)

1 reference

Europe PubMed Central

11 September 2017

acute pancreatitis

1 reference

based on heuristic

inferred from title

author name string

Hongyu Wan

1

1 reference

Europe PubMed Central

11 September 2017

Yaozong Yuan

2

1 reference

Europe PubMed Central

11 September 2017

Jiansheng Liu

3

1 reference

Europe PubMed Central

11 September 2017

Guohong Chen

4

1 reference

Europe PubMed Central

11 September 2017

publication date

28 February 2012

1 reference

Europe PubMed Central

11 September 2017

Translational Research

1 reference

Europe PubMed Central

11 September 2017

160

1 reference

Europe PubMed Central

11 September 2017

2

1 reference

Europe PubMed Central

11 September 2017

153-161

1 reference

Europe PubMed Central

11 September 2017

Early trypsinogen activation in acute pancreatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

PPAR and immune system--what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Early events in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Effect of hyperthermia on NF-kappaB binding activity in cerulein-induced acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Chemokines: leucocyte recruitment and activation cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Transcriptional Coactivator PRIP, the Peroxisome Proliferator-activated Receptor γ (PPARγ)-interacting Protein, Is Required for PPARγ-mediated Adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.02.003

7 January 2021

Identifiers

10.1016/J.TRSL.2012.02.003

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39335219&oldid=1820617140"